KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non-cash Items: 2010-2011

  • Vertex Pharmaceuticals' Non-cash Items fell 51.49% to $56.4 million in Q4 2011 from the same period last year, while for Dec 2011 it was $56.4 million, marking a year-over-year decrease of 51.49%. This contributed to the annual value of $56.4 million for FY2011, which is 51.49% down from last year.
  • As of Q4 2011, Vertex Pharmaceuticals' Non-cash Items stood at $56.4 million, which was down 51.49% from $116.2 million recorded in Q4 2010.
  • Over the past 5 years, Vertex Pharmaceuticals' Non-cash Items peaked at $116.2 million during Q4 2010, and registered a low of $56.4 million during Q4 2011.
  • Over the past 2 years, Vertex Pharmaceuticals' median Non-cash Items value was $86.3 million (recorded in 2010), while the average stood at $86.3 million.
  • Data for Vertex Pharmaceuticals' Non-cash Items shows a maximum YoY slumped of 51.49% (in 2011) over the last 5 years.
  • Over the past 2 years, Vertex Pharmaceuticals' Non-cash Items (Quarterly) stood at $116.2 million in 2010, then slumped by 51.49% to $56.4 million in 2011.